Biostatistics and Data Management Center 22 January 2016 Report from the Biostatistics and Data Management Center Constantine Gatsonis, PhD ACRIN Biostatistics.

Slides:



Advertisements
Similar presentations
Decision Support Capability Breast Cancer Scenarios
Advertisements

Advanced breast cancer
Assessment of Radiologists’ Performance with CADe for Digital Mammography Elodia B. Cole, MS Medical University of South Carolina Department of Radiology.
Role of the Statistician and the Bioinformatics Scientist in Cancer Clinical Trials Larry Rubinstein, PhD Biometric Research Branch, NCI International.
Enterprise Use Cases. Levels LevelDescriptionExamples 0 0aVerbal CommunicationNon-permanent, e.g. verbal communication 1Non-electronic dataMail, phone.
EUROCHIP PILOT STUDIES. Collection of detailed clinical information for specific tumours Describing and comparing care in representative samples of cancer.
Digital Imaging in Dentistry Applications and Challenges
March 3, 2014 IN SIXTY: Cancer Patient Journey. RELEASE AVAILABLE AT:
ACRIN Breast Committee October 1, 2010 Constance Lehman, M.D., PhD, FACR Professor and Vice Chair of Radiology University of Washington ACRIN Breast Committee.
11/29/2004RSNA ACCURACY OF AXILLARY FDG-PET FOR STAGING PRIMARY BREAST CANCER: A META-ANALYSIS BEN A. DWAMENA; GAVIN MACKIE; DIANE THANAGAMI; MARK.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
Long-term predictive value of assessment of coronary atherosclerosis by contrast- enhanced coronary computed tomography angiography: meta- analysis and.
RADIOLOGY Technology Trends and Their Impact on American Healthcare Monte Clinton, CRA Director of Radiology Dartmouth-Hitchcock Medical Center Lebanon,
Discordance in Hormone Receptor and HER2 Status in Breast Cancer during Tumor Progression Lindstrom LS et al. Proc SABCS 2010;Abstract S3-5.
Clinical Utility of Combidex in Various Cancers
1 © 2015, Elsevier Inc., Heymann, Bone Cancer, Second Edition Chapter 45 DIAGNOSIS OF BONE METASTASES IN UROLOGICAL MALIGNANCIES - AN UPDATE.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
GOG 0233/ACRIN 6671 UPDATE & CHALLENGES UTILITY OF PET/CT & USPIO MRI IN DETECTION OF LYMPHADENOPATHY IN LOCOREGINALLY ADVANCED CERVIX CANCER ACRIN 2008.
Living Beyond Breast Cancer Liver and Lung Metastases Workshop April 29, 2012 Paul B. Gilman, MDLankenau Medical Center.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
Grants. The mission of the Quantitative Imaging Network (QIN) is to improve the role of quantitative imaging for clinical decision making in oncology.
Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for.
Imaging Workspace An Overview and Roadmap Eliot L. Siegel, MD Imaging Workspace Lead SME January 23, 2008.
ACRIN Annual Meeting 2010 Mitchell Schnall MD, PhD Professor of Radiology University of Pennsylvania ACRIN Network Chair State of ACRIN : Working to secure.
1 NOPR 2006: Results and Lessons Learned 2010 Annual AHRQ Conference NOPR 2006: Results and Lessons Learned 2010 Annual AHRQ Conference Bruce E. Hillner,
ACRIN BDMC Fall 2011 Biostatistics and Data Management Center Constantine Gatsonis, PhD Department of Biostatistics Center for Statistical Sciences Brown.
Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute.
ACRIN Breast Committee Fall Meeting : Comparison of Full-Field Digital Mammography with Digital Breast Tomosynthesis Image Acquisition in Relation.
Imaging Questions in Ovarian Cancer Susanna I. Lee, MD, PhD.
ACRIN Fall Meeting 2008 Mitchell Schnall MD, PhD Professor of Radiology University of Pennsylvania ACRIN Network Chair State of ACRIN : 10 years of investment.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
The Quantitative Imaging Network (QIN) Robert Nordstrom, Ph.D. Larry Clarke, Ph.D.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/2/09.
ACRIN Fall Meeting 2010 BDMC Report and Perspective Constantine Gatsonis, PhD ACRIN Biostatistics and Data Management Center Brown University.
State of ACRIN : Extending our reach
ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.
ACRIN Fall Meeting 2010 RESCUE Design and Analysis plans Constantine Gatsonis, PhD ACRIN Biostatistics and Data Management Center Brown University.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 9/30/10.
Introduction Of Taipei City Hospital -RenAi Branch
NFBIO: Update on NCI Imaging Activities Daniel C. Sullivan, M.D. Cancer Imaging Program, DCTD, NCI.
YOU: YOUR OWN BEST MEDICINE Care Transition Outcomes Effectiveness & Experience Simple, Insightful, Engaging.
Symptom control in patients with recurrent ovarian cancer Measuring the benefit of palliative chemotherapy in women with platinum refractory/ resistant.
CDRP Program Update UPMC McKeesport Program Steering Committee RTOG Meeting Toronto, Canada June 23 rd, 2006.
ACRIN 6682 Phase II Trial OF 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/4/08.
Albert J. Chang, MD, PhD 1 Farrokh Dehdashti, MD 2 Perry W. Grigsby, MD, MS 1 Department of Radiation Oncology 1 Department of Radiology and Nuclear Medicine.
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
ACRIN Breast Committee Fall Meeting CADe study Etta Pisano, MD Martin Yaffe PhD Elodia Cole, MS Zheng Zhang, PhD ACRIN Breast Committee.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Welcome to Asian Institute of Medical Sciences
ECOG-ACRIN Studies with Novel PET/CT Imaging
What are the best radiology fellowship programs today?
An Introduction to: rscan.org. What is R-SCAN? 2 A clinical practice improvement activity for radiologists and referring practitioners to:  Improve imaging.
ACOSOG Sarcoma Committee Chair: Peter W.T. Pisters, MD Vice Chairs: Edward Cheng, MD (Orthopedic Oncology) Robert Maki, MD, PhD (Medical Oncology) Brian.
This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in.
TMIST A Breast Cancer Screening Trial
Indications for Breast MR Imaging
SAR 2017 Annual Scientific Meeting and Educational Course
Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer Eur Thyroid J 2016;5:
Applications of Diagnostic Imaging Computed Tomography
How do we delay disease progress once it has started?
Applications of Diagnostic Imaging Magnetic Resonance Imaging
سرطان الثدي Breast Cancer
System Optimizations Work Group Update
Comments on design and sequence of biomarker studies
Chapter 17 Intensity-Modulated Radiation Therapy
Introduction Diagnostics Data Service Existing Standards
Shandong Wu, PhD Assistant Professor
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Presentation transcript:

Biostatistics and Data Management Center 22 January 2016 Report from the Biostatistics and Data Management Center Constantine Gatsonis, PhD ACRIN Biostatistics and Data Management Center Brown University Providence, RI

Biostatistics and Data Management Center  Major emphasis on developing and launching new studies:  Cancer: 6681, 6682, 6683, 6684, 6685, 6686, 6687, 6688, 6689, 6690, 6691  Cardiovascular: 4005  Analysis for primary and secondary papers and abstracts in several protocols:  6652, 6654, 6657, 6660, 6661, 6664, 6665, 6666, 6667, 6668, 6673, 6677, 6683 BDMC : Highlights

Biostatistics and Data Management Center  Imaging-based biomarkers for predicting response to therapy and long term outcomes.  Majority of new studies  CAD evaluation.  Accuracy in diagnosis and staging.  Diagnostic test impact on outcomes.  Significant methodologic and practical challenges Themes of new studies

Biostatistics and Data Management Center  Cu64-ATSM PET for cervical cancer (6682)  FMISO in glioblastoma (6684)  DCE-MRI, DSC-MRI in glioblastoma(6686)  F-Fluoride PET in prostate cancer (6687)  FLT PET in breast cancer (6688)  FLT PET and DCE-MRI in glioblastoma (6689)  Optimal imaging in breast cancer (6691) Predicting response

Biostatistics and Data Management Center  CAD for CT Colonography (6681)  CAD for mammography (6683)  PET/CT for head and neck cancer (6685)  CDE-MRI and DCE-CT for HCC in liver transplant candidates (6690) Accuracy: diagnosis and staging

Biostatistics and Data Management Center  CT angiography in the emergency room: Randomized comparison to usual care (4005).  Preoperative MRI for women with breast cancer: Randomized study of impact on surgical outcomes, recurrence, quality of life and cost. (in development) Impact on outcomes

Biostatistics and Data Management Center  Analysis for primary and secondary papers and abstracts in several protocols:  6652, 6654, 6657, 6660, 6661, 6664, 6665, 6666, 6667, 6668, 6673, 6677, 6683  Solid presence at RSNA.  Abstracts at ASCO and other conferences.  Publications volume needs to increase.  Paper writing needs more attention and energy. Analysis and publications

Biostatistics and Data Management Center  Needs identified (from last year’s presentation ): Fully electronic data management Improved data entry capabilities Automated system for tracking data queries.  Progress update : Finally close to making decisions on choice of new system. Transition will be a significant undertaking. Informatics and Data Management

Biostatistics and Data Management Center It has been quite a ride!